Cytek Biosciences annual total assets
2020
2021
2022
2023
2024
2025
Cytek Biosciences Total Assets Growth & History (CTKB)
Cytek Biosciences's total assets was $461.5M for fiscal 2025.
View full Cytek Biosciences company overviewCytek Biosciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $461.5M | −$38.0M | −7.60% |
| 2024 | 2024-12-31 | $499.5M | $5.0M | +1.02% |
| 2023 | 2023-12-31 | $494.5M | −$25.0M | −4.82% |
| 2022 | 2022-12-31 | $519.5M | $56.2M | +12.12% |
| 2021 | 2021-12-31 | $463.3M | $243.3M | +110.61% |
| 2020 | 2020-12-31 | $220.0M | — | — |
Cytek Biosciences quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $446.9M | −$46.4M | −9.40% |
| Q1 2026 | 2026-03-31 | $449.1M | −$33.5M | −6.94% |
| Q4 2025 | 2025-12-31 | $461.5M | −$38.0M | −7.60% |
| Q3 2025 | 2025-09-30 | $494.9M | $3.7M | +0.75% |
| Q2 2025 | 2025-06-30 | $493.3M | $9.6M | +1.98% |
| Q1 2025 | 2025-03-31 | $482.6M | −$9.5M | −1.92% |
| Q4 2024 | 2024-12-31 | $499.5M | $5.0M | +1.02% |
| Q3 2024 | 2024-09-30 | $491.2M | −$28.2M | −5.43% |
| Q2 2024 | 2024-06-30 | $483.7M | −$41.3M | −7.87% |
| Q1 2024 | 2024-03-31 | $492.1M | −$32.5M | −6.20% |
| Q4 2023 | 2023-12-31 | $494.5M | −$25.0M | −4.82% |
| Q3 2023 | 2023-09-30 | $519.4M | $20.1M | +4.03% |
| Q2 2023 | 2023-06-30 | $525.1M | $32.2M | +6.54% |
| Q1 2023 | 2023-03-31 | $524.6M | $38.7M | +7.96% |
| Q4 2022 | 2022-12-31 | $519.5M | $56.2M | +12.12% |
| Q3 2022 | 2022-09-30 | $499.3M | $45.0M | +9.90% |
| Q2 2022 | 2022-06-30 | $492.8M | $262.5M | +114.01% |
| Q1 2022 | 2022-03-31 | $485.9M | — | — |
| Q4 2021 | 2021-12-31 | $463.3M | $243.3M | +110.61% |
| Q3 2021 | 2021-09-30 | $454.3M | — | — |
| Q2 2021 | 2021-06-30 | $230.3M | — | — |
| Q4 2020 | 2020-12-31 | $220.0M | — | — |
Cytek Biosciences total assets trends
Over the last five fiscal years, Cytek Biosciences's total assets increased from $220.0M to $461.5M, a change of $241.6M. The latest reported quarter, Q2 2026, shows $446.9M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cytek Biosciences source filings ↗